BMC Cancer (Jun 2019)

Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

  • Edith A. Perez,
  • Sanne Lysbet de Haas,
  • Wolfgang Eiermann,
  • Carlos H. Barrios,
  • Masakazu Toi,
  • Young-Hyuck Im,
  • Pier Franco Conte,
  • Miguel Martin,
  • Tadeusz Pienkowski,
  • Xavier B. Pivot,
  • Howard A. Burris,
  • Sven Stanzel,
  • Monika Patre,
  • Paul Anthony Ellis

DOI
https://doi.org/10.1186/s12885-019-5831-x
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 2

Abstract

Read online

Following publication of the original article [1], the authors reported the following errors in the article.